Market Place
Sourcing Support
All News #Library
Biotech
Sapience Therapeutics Presents Phase 2 ST-316 Data at AACR 2026
20 Apr 2026 //
PR NEWSWIRE
Sapience Presents ST316 Ph 1 Dose Data at ASCO GI Cancers Symposium
27 Jan 2025 //
PR NEWSWIRE
Sapience Announces Multiple Presentations At SITC 39th Meeting
08 Oct 2024 //
PR NEWSWIRE
Sapience Enrolls First Patient in Phase 2 Colorectal Cancer Study
01 Oct 2024 //
PR NEWSWIRE
Sapience`s ST101 Shows Positive GBM Data, Biomarkers In ASCO Oral Session
01 Jun 2024 //
PR NEWSWIRE
Sapience St101 Glioblastoma Featured: Phase 2 Clinical Biomarkers Asco
23 May 2024 //
PR NEWSWIRE
Sapience Therapeutics Presents Three Posters at the AACR Annual Meeting 2024
08 Apr 2024 //
PR NEWSWIRE
Sapience Therapeutics Presents ST101 Clinical Data and ST316 Preclinical Data
13 Oct 2023 //
PR NEWSWIRE
Sapience Announces First Patient Dosed in Phase 1-2 Clinical Study of ST316
13 Jun 2023 //
PR NEWSWIRE
Sapience Announces Research Poster Presentations on ST101 and ST316
16 Mar 2023 //
PR NEWSWIRE
Sapience Receives IND Clearance from FDA to Proceed with Ph 1-2 Study of ST316
14 Mar 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.